InsiderTrades

Form 4 for SGHT Sight Sciences, Inc.

Accepted 2025-05-29 00:00:00 ET · period of report 2025-05-27 · accession 0000950170-25-079292 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2025-05-29 2025-05-27+ SGHT Encrantz Staffan Dir, 10% P - Purchase $3.53 +128.2K 1.16M +12% +$452.1K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-05-27 P A 41,346 $3.44 1,070,862 D — — (F1) The price reported in Column 4 is a weighted average price. These shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), were purchased in multiple transactions at per share prices ranging from $3.29 to $3.46 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
2 Common Common Stock 2025-05-28 P A 26,715 $3.52 1,097,577 D — — (F2) The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at per share prices ranging from $3.325 to $3.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
3 Common Common Stock 2025-05-29 P A 60,128 $3.59 1,157,705 D — — (F3) The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at per share prices ranging from $3.50 to $3.71 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. (F4) Includes (i) 1,140,339 shares of Common Stock and (ii) 17,366 restricted stock units, which are subject to vesting as previously reported.